TRIM8 and central nervous system cancer: Specifically, the loss of one copy of TRIM8 gene was observed in approximately 9.9 % of gliomas of grade II, 32.8 % of grade III, and 91.8 % of glioblastomas (Fig. 2b, p < 0.001).